NUMD OTC
Nu-Med Plus, Inc.
1W: -36.5%
1M: -40.2%
3M: +33.3%
YTD: +2.8%
1Y: -53.2%
3Y: -36.5%
5Y: -88.8%
$0.01
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$63K
+47.5% ▲
Net Income
-$68K
+45.6% ▲
EPS (Diluted)
$-0.00
+46.7% ▲
EBITDA
$0
+100.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $19K | $23K | $13K | $13K | $0 |
| Gross Profit | -$19K | -$23K | -$13K | -$13K | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2M | $830K | $180K | $121K | $63K |
| Operating Expenses | $2M | $839K | $182K | $121K | $63K |
| Operating Income | -$2M | -$839K | -$182K | -$121K | -$63K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $14K | $0 | $1K | $5K | $5K |
| Income Before Tax | -$2M | -$830K | -$130K | -$126K | -$68K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2M | -$830K | -$130K | -$126K | -$68K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.04 | $-0.01 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$2M | -$818K | -$172K | -$118K | $0 |
| Shares Outstanding | 55M | 73M | 80M | 82M | 84M |